Induced protein degradation: an emerging drug discovery paradigm
Crossref DOI link: https://doi.org/10.1038/nrd.2016.211
Published Online: 2016-11-25
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lai, Ashton C.
Crews, Craig M.
Text and Data Mining valid from 2016-11-25
Article History
First Online: 25 November 2016
Competing interests
: C.M.C. is a founder, consultant and shareholder of Arvinas, LLC. A.C.L. declares no competing interests.